ChengDu ShengNuo Biotec Co.,Ltd.
Shanghai Stock ExchangeTotal Valuation
ChengDu ShengNuo Biotec Co.,Ltd. carries a market capitalization of 6.76B, placing it among publicly traded companies globally. Its enterprise value stands at 5.87B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 6.76B |
| Enterprise Value | 5.87B |
Share Statistics
ChengDu ShengNuo Biotec Co.,Ltd. currently has 220.34M shares outstanding.
| Shares Outstanding | 220.34M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
ChengDu ShengNuo Biotec Co.,Ltd. trades at a trailing price-to-earnings ratio of 40.20. The price-to-sales ratio is 9.04, and the price-to-book ratio stands at 7.38.
| PE Ratio | 40.20 |
| PS Ratio | 9.04 |
| PB Ratio | 7.38 |
| P/TBV Ratio | 5.43 |
| P/FCF Ratio | 59.63 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, ChengDu ShengNuo Biotec Co.,Ltd. trades at an EV/EBITDA multiple of 28.23 and an EV/FCF ratio of 56.07. The EV/Sales ratio of 9.49 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 28.23 provides insight into valuation relative to core operating earnings.
| EV / Sales | 9.49 |
| EV / EBITDA | 28.23 |
| EV / EBIT | 28.23 |
| EV / FCF | 56.07 |
Financial Position
ChengDu ShengNuo Biotec Co.,Ltd. maintains a current ratio of 2.12, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 51.25, indicating elevated leverage, while an interest coverage ratio of 15.90 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.12 |
| Quick Ratio | 0.67 |
| Debt / Equity | 51.25 |
| Debt / EBITDA | 2.77 |
| Interest Coverage | 15.90 |
Financial Efficiency
ChengDu ShengNuo Biotec Co.,Ltd. posts a return on equity of 21.16 and a return on invested capital of 11.00.
| Return on Equity (ROE) | 21.16 |
| Return on Assets (ROA) | 7.57 |
| Return on Invested Capital (ROIC) | 11.00 |
| Return on Capital Employed (ROCE) | 12.78 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.77 |
Taxes
Over the trailing twelve months, ChengDu ShengNuo Biotec Co.,Ltd. has paid 27.51M in income taxes, reflecting an effective tax rate of 16.51.
| Income Tax | 27.51M |
| Effective Tax Rate | 16.51 |
Stock Price Statistics
ChengDu ShengNuo Biotec Co.,Ltd.'s stock has gained approximately 22.7509% over the past 52 weeks. The 50-day moving average sits at 25.26, while the 200-day moving average is 27.18.
| Beta (5Y) | N/A |
| 52-Week Price Change | 22.7509% |
| 50-Day Moving Average | 25.26 |
| 200-Day Moving Average | 27.18 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, ChengDu ShengNuo Biotec Co.,Ltd. generated 618.86M in revenue and converted that into 139.11M in net income, yielding earnings per share of 0.63. EBITDA reached 207.97M, while operating income came in at 207.97M.
| Revenue | 618.86M |
| Gross Profit | 367.60M |
| Operating Income | 207.97M |
| Pretax Income | 166.63M |
| Net Income | 139.11M |
| EBITDA | 207.97M |
| EBIT | 207.97M |
| Earnings Per Share (EPS) | 0.63 |
Balance Sheet
ChengDu ShengNuo Biotec Co.,Ltd. holds 297.72M in cash and equivalents against 576.43M in total debt, resulting in a net debt position of 288.18M. Total book value stands at 757.83M, with working capital of 501.31M providing operational flexibility.
| Cash & Cash Equivalents | 297.72M |
| Total Debt | 576.43M |
| Net Debt | 288.18M |
| Equity (Book Value) | 757.83M |
| Book Value Per Share | 3.43 |
| Working Capital | 501.31M |
Cash Flow
After subtracting -93.79M in capital expenditures, free cash flow totaled -93.79M - equivalent to -0.42 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -93.79M |
| Free Cash Flow | -93.79M |
| FCF Per Share | -0.42 |
Margins
ChengDu ShengNuo Biotec Co.,Ltd. operates with a gross margin of 59.40, reflecting its pricing power and cost economics. The operating margin of 33.61 and net profit margin of 22.48 provide insight into operational efficiency.
| Gross Margin | 59.40 |
| Operating Margin | 33.61 |
| Pretax Margin | 26.93 |
| Profit Margin | 22.48 |
| EBITDA Margin | 33.61 |
Dividends & Yields
The company's payout ratio of 24.15 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.15 |
| Dividend Yield | N/A |
| Payout Ratio | 24.15 |
| Shareholder Yield | -0.55 |
| FCF Yield | 1.68 |
Stock Splits
ChengDu ShengNuo Biotec Co.,Ltd.'s most recent stock split took place on June 5, 2026 with a 5:7 split ratio.
| Last Split Date | 6/5/2026 |
| Split Ratio | 5:7 |
Scores
ChengDu ShengNuo Biotec Co.,Ltd. posts an Altman Z-Score of 5.23, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 5.23 |